Yu Qingming, chairman of Sinopharm Holdings, a subsidiary of China National Drug Corporation (Sinopharm), recently revealed that the antibodies to the New Crown pneumonia vaccine, which Sinopharm executives received a year ago, are still in place. This statement has sparked an outcry. Netizens have questioned how to understand that Li Wenliang, the “whistle blower” of the Wuhan Epidemic in January last year, was accused of disinformation, but then the vaccine appeared.
I don’t know if it was a “wild word” or a real thing. During the “two sessions” of China’s National People’s Congress, a comment by a senior executive of Sinopharm, the producer of China’s new coronavirus vaccine, caused a public outcry. According to a report published on Sina.com on March 6 by the Voice of China, Yu Qingming, chairman of Sinopharm Holdings, a subsidiary of Sinopharm, revealed during the “Two Sessions” that antibodies to the coronavirus (COVID-19) vaccine that Sinopharm executives received a year ago are still present, sparking an outcry on the Internet.
Sina Weibo user “Chen Dong Xin Yu” wrote in a message on Tuesday (9) that the first confirmed case of new coronavirus pneumonia in Wuhan was diagnosed on December 8, 2019, and Li Wenliang was admonished on January 3, 2020, and was still debunking the rumors. Less than 3 months, the head of the party and government of the State Drug four enterprises on the vaccine “to test the drug”, really divine. Great.
Xu Yang, a resident of Wuhan who experienced the closure of the city last year, said in an interview with Radio Free Asia on Wednesday that it was scary to hear the news: “The first reaction is that I feel creeped out, and now people don’t pay attention to whether vaccines are safe or not. Another more serious question that arises is how the vaccine could be developed in such a short period of Time. According to the scientific common sense understanding, this is not possible. According to the Xinhua News Agency, it will take at least one or two or three or five years to get this (New Crown) vaccine produced.”
China was the first to start developing the new crown vaccine
Caixin quoted the health Times as reporting that Yu Qingming, a deputy to China’s National People’s Congress and secretary of the party committee and chairman of Sinopharm Holdings, a Sinopharm group, revealed that in March 2020, the party and government leaders of Sinopharm’s four levels of enterprises received the vaccine, and after a year of continuous antibody tracking and monitoring, the antibodies are still all maintained at a high level with no significant decline. Sinopharm continues to expand its production capacity, and the annual production capacity of the new crown vaccine will reach 3 billion doses, which is currently the world’s largest producer of the new crown vaccine.
Xu Yang said this shows that Sinopharm learned about the infectiousness of the New crown outbreak very early last year: “He knew early on that the outbreak was happening. This is even earlier than the January 23 closure of Wuhan, which should have been before that, and this is another big iron-clad proof that the authorities concealed the epidemic and exposed themselves (to the epidemic), how they knew about the epidemic so early, and where this virus actually came from, is too terrible to imagine.”
Zhang Hai, a Family member of a victim of the Wuhan epidemic, was surprised that the top management of Sinopharm had injected the vaccine a year ago. He told the station, “The fact that Sinopharm executives had been vaccinated a year ago gives me the feeling that the outbreak must not have suddenly broken out in Wuhan. Because I also saw a report before that just said Wuhan organized an epidemic drill against the new crown virus, which means that the virus outbreak in Wuhan was a deliberate criminal act of murder. As time passes, many things will come to light.”
Public information shows that China National Pharmaceutical Group, established in 1998, is a large state-owned enterprise whose main business is Medicine and health and other products, with more than 1,000 subsidiaries and six listed companies, including Sinopharm Holdings and Sinopharm Corporation. The number of employees is 110,000.
Sina.com reported that Yu Qingming, a deputy to the National People’s Congress and chairman of Sinopharm, revealed that the group tried vaccines with its body a year ago. (Web screenshot)
Recent Comments